SERAC1 Antikörper (C-Term)
Kurzübersicht für SERAC1 Antikörper (C-Term) (ABIN2366243)
Target
Alle SERAC1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 555-585, C-Term
-
Kreuzreaktivität
- Human, Maus
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo
-
Produktmerkmale
- SRAC1, CT (SERAC1, Protein SERAC1)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- SRAC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 555-585 amino acids from the C-terminal region of human SRAC1.
-
Isotyp
- IgG
-
-
anti-Serine Active Site Containing 1 (SERAC1) (AA 552-581), (C-Term) antibody
SERAC1 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB28676 unconjugated
anti-Serine Active Site Containing 1 (SERAC1) (AA 41-64), (N-Term) antibodySERAC1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB50081 unconjugated
anti-Serine Active Site Containing 1 (SERAC1) (AA 176-225) antibodySERAC1 Reaktivität: Human, Ratte, Meerschweinchen, Pferd, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Serine Active Site Containing 1 (SERAC1) (AA 555-585), (C-Term) antibodySERAC1 Reaktivität: Human, Maus WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- SERAC1 (Serine Active Site Containing 1 (SERAC1))
-
Andere Bezeichnung
- SRAC1
-
NCBI Accession
- NP_116250
-
UniProt
- Q96JX3
-
Pathways
- Inositol Metabolic Process
Target
-
